VA

A commonly-used heart drug, digoxin, has never passed a controlled-study test to see if it s both safe and effective for patients with atrial fibrillation. A large VA retrospective analysis shows that it may be even riskier than suspected: maybe time for it to go.
A fairly large, retrospective study of almost 8,000 VA male patients who had a coronary arterial study and had low testosterone levels, found that those men who got supplemental testosterone had a 30% increase rate of CVD events, compared to those men who did not get testosterone treatment.